# US 2003/0212253 A1 · Plasma protein-binding ligands

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0212253 A1
- Document ID: US20030212253A1
- Status: Published application
- Kind: A1
- Application number: 10/414,524
- Filed: 2003-04-14
- Published: 2003-11-13
- Earliest claimed: 2002-04-15
- Assignees: American National Red Cross
- Inventors: David J. Hammond; Julia Tait Lathrop; Annemarie Ralston; Timothy K. Hayes; Iwona Fijalkowska
- Web page: https://patentgrep.com/patent/US20030212253A1

## CPC

- G01N 33/54306: {Solid-phase reaction mechanisms}
- C07K 1/047: {Simultaneous synthesis of different peptide species; Peptide libraries}
- C07K 1/14: Extraction; Separation; Purification
- C07K 5/0812: {and aromatic or cycloaliphatic}
- C07K 5/0815: {with the first amino acid being basic}
- C07K 5/0821: {with the first amino acid being heterocyclic, e.g. His, Pro, Trp}
- C07K 5/1008: {the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala}
- C07K 7/06: having 5 to 11 amino acids
- G01N 33/54313: {the carrier being characterised by its particulate form}
- G01N 33/54386: {Analytical elements}
- Y02P 20/582: Recycling of unreacted starting or intermediate materials
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The invention provides an isolated or purified peptide that binds at least one plasma protein. In one embodiment, the isolated or purified peptide binds to fibrinogen, comprises no more than 10 amino acids, and comprises an amino acid sequence Xaa1-Xaa2-Xaa3-Xaa4-Xaa5, an amino acid sequence Gly-Xaa6-Arg-Xaa7, or an amino acid sequence selected from specific amino acid sequences provided herein. Alternatively, the isolated or purified protein binds to al proteinase inhibitor and/or a protein complex comprising Apo-A1 lipoprotein and paraoxonase. The peptide comprises no more than 10 amino acids and comprises an amino acid sequence Xaa8-Xaa8-Xaa1-His-Xaa1-Xaa3, and amino acid sequence His-Xaa8-Xaa9-Xaa1-Xaa10-Xaa2, or an amino acid sequence selected from specific amino acid sequences provided herein. In addition, the invention provides isolated or purified peptide that binds to von Willebrand Factor. The peptide comprises an amino acid sequence Xaa4-Xaa5-Xaa5, an amino acid sequence Tyr-Leu-Xaa11-Xaa4-Xaa12-Thr, or an amino acid sequence selected from specific amino acid sequences provided herein.

## Claims

### Claim 1

An isolated or purified peptide comprising no more than 10 amino acids and comprising an amino acid sequence Xaa1-Xaa2-Xaa3-Xaa4-Xaa5 (SEQ ID NO: 1), wherein
Xaa1 is a hydrophobic amino acid,
Xaa2 is a basic amino acid,
Xaa3 is a polar amino acid with a side chain comprising an amide,
Xaa4 is a hydrophobic amino acid or an aromatic amino acid, and
Xaa5 is an acidic amino acid,
and wherein the peptide binds to fibrinogen.

### Claim 2 (depends on 1)

The isolated or purified peptide of claim 1, wherein the amino acid sequence comprises an N-terminal amino acid that is a D-amino acid.

### Claim 3 (depends on 2)

The isolated or purified peptide of claim 2, wherein Xaa1 is Ala, Xaa2 is Arg, Xaa3 is Asn or Gln, and Xaa5 is Asp.

### Claim 4 (depends on 3)

The isolated or purified peptide of claim 3, wherein the peptide consists essentially of SEQ ID NO: 20 or SEQ ID NO: 21.

### Claim 5 (depends on 1)

A composition comprising the peptide of claim 1 and a carrier.

### Claim 6

An isolated or purified peptide comprising no more than 10 amino acids and comprising an amino acid sequence Gly-Xaa6-Arg-Xaa7 (SEQ ID NO: 2), wherein
Xaa6 is Pro or Gln, and
Xaa7 is any amino acid except Pro,
and wherein the peptide binds to fibrinogen.

### Claim 7 (depends on 6)

The isolated or purified peptide of claim 6, wherein Xaa6 is Pro.

### Claim 8 (depends on 6)

The isolated or purified peptide of claim 6, wherein the peptide consists essentially of an amino acid sequence selected from the group consisting of SEQ ID NOs: 16, 22-27, and 29-32.

### Claim 9 (depends on 6)

A composition comprising the peptide of claim 6 and a carrier.

### Claim 10

An isolated or purified peptide comprising no more than 10 amino acids and comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 7-15, 17-19, and 28, wherein the peptide binds to fibrinogen.

### Claim 11 (depends on 11)

The isolated or purified peptide of claim 11, wherein the amino acid sequence is selected from the group consisting of SEQ ID NOs: 17-19 and comprises an N-terminal amino acid that is a D-amino acid.

### Claim 12 (depends on 1)

A method of separating, isolating, purifying, characterizing, identifying, or quantifying fibrinogen in a sample, which method comprises (a) contacting a sample comprising fibrinogen with the peptide of claim 1 to form a fibrinogen-peptide complex, and (b) separating, isolating, purifying, characterizing, identifying, or quantifying the fibrinogen-peptide complex.

### Claim 13 (depends on 12)

The method of claim 12, wherein the peptide is attached to a support.

### Claim 14 (depends on 13)

The method of claim 13, wherein the support is a chromatography resin or a membrane.

### Claim 15 (depends on 12)

The method of claim 12, wherein the peptide consists essentially of an amino acid sequence of SEQ ID NO: 20 or SEQ ID NO: 21.

### Claim 16 (depends on 6)

A method of separating, isolating, purifying, characterizing, identifying, or quantifying fibrinogen in a sample, which method comprises (a) contacting a sample comprising fibrinogen with the peptide of claim 6 to form a fibrinogen-peptide complex, and (b) separating, isolating, purifying, characterizing, identifying, or quantifying the fibrinogen-peptide complex.

### Claim 17 (depends on 16)

The method of claim 16, wherein the peptide is attached to a support.

### Claim 18 (depends on 17)

The method of claim 17, wherein the support is a chromatography resin or a membrane.

### Claim 19 (depends on 10)

A method of separating, isolating, purifying, characterizing, identifying, or quantifying of removing fibrinogen in a sample, which method comprises (a) contacting a sample comprising fibrinogen with the peptide of claim 10 to form a fibrinogen-peptide complex, and (b) separating, isolating, purifying, characterizing, identifying, or quantifying the fibrinogen-peptide complex.

### Claim 20 (depends on 19)

The method of claim 19, wherein the peptide is attached to a support.

### Claim 21 (depends on 20)

The method of claim 20, wherein the support is a chromatography resin or a membrane.

### Claim 22

An isolated or purified peptide comprising no more than 10 amino acids and comprising an amino acid sequence Xaa8-Xaa8-Xaa1-His-Xaa1-Xaa3 (SEQ ID NO: 3), wherein
Xaa1 is hydrophobic amino acid,
Xaa3 is a polar amino acid with a side chain comprising an amide, and
Xaa8 is an aromatic amino acid, and
wherein the peptide binds to α1 proteinase inhibitor (API) and/or a protein complex comprising paraoxonase and Apo-A1 lipoprotein.

### Claim 23 (depends on 22)

The isolated or purified peptide of claim 22, wherein Xaa8 at position 1 is Trp, Tyr, 1-naphthylalanine (na1′), or 2-naphthylalanine (na2′), and Xaa3 at position 6 is Asn or Gln.

### Claim 24 (depends on 23)

The isolated or purified peptide of claim 23, wherein Xaa8 at position 2 is Trp, Tyr, na1′, or na2′, Xaa1 at position 3 is Leu, and Xaa1 at position 5 is Ile.

### Claim 25 (depends on 22)

The isolated or purified peptide of claim 22, wherein amino acid sequence comprises an N-terminal amino acid that is a D-amino acid.

### Claim 26 (depends on 22)

A composition comprising the peptide of claim 22 and a carrier.

### Claim 27

An isolated or purified peptide comprising no more than 10 amino acids and comprising an amino acid sequence His-Xaa8-Xaa9-Xaa1-Xaa10-Xaa2 (SEQ ID NO: 4), wherein
Xaa1 is a hydrophobic amino acid,
Xaa2 is a basic amino acid,
Xaa8 is an aromatic amino acid,
Xaa9 is an acidic amino acid or a hydrophobic amino acid, and
Xaa10 is a hydrophobic amino acid or His,
and wherein the peptide binds to API.

### Claim 28 (depends on 27)

The isolated or purified peptide of claim 27, wherein the peptide consists essentially of L-amino acids.

### Claim 29 (depends on 27)

The isolated or purified peptide of claim 27, wherein the peptide consists essentially of an amino acid sequence of SEQ ID NO: 46 or SEQ ID NO: 47.

### Claim 30 (depends on 27)

A composition comprising the peptide of claim 27 and a carrier.

### Claim 31

An isolated or purified peptide comprising no more than 10 amino acids and comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 36, 38, 39, 45, 48, 54, and 55, wherein the peptide binds to API.

### Claim 32 (depends on 31)

The isolated or purified peptide of claim 31, wherein the amino acid sequence comprises an N-terminal amino acid that is a D-amino acid.

### Claim 33 (depends on 31)

A composition comprising the peptide of claim 31 and a carrier.

### Claim 34

An isolated or purified peptide comprising no more than 10 amino acids and comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 59-62, wherein the peptide binds to a protein complex comprising Apo-A1 lipoprotein and paraoxonase.

### Claim 35 (depends on 34)

A composition comprising the peptide of claim 34 and a carrier.

### Claim 36 (depends on 22)

A method of separating, isolating, purifying, characterizing, identifying, or quantifying API and/or a protein complex comprising Apo-A1 lipoprotein and paraoxonase in a sample, which method comprises (a) contacting a sample comprising API and/or a protein complex comprising Apo-A1 lipoprotein and paraoxonase with the peptide of claim 22 to form an API-peptide complex or a complex comprising the peptide and Apo-A1 lipoprotein and/or paraoxonase, and (b) separating, isolating, purifying, characterizing, identifying, or quantifying the API-peptide complex and/or the complex comprising the peptide and Apo-A1 lipoprotein and/or paraoxonase.

### Claim 37 (depends on 36)

The method of claim 36, wherein the peptide is attached to a support.

### Claim 38 (depends on 37)

The method of claim 37, wherein the support is a chromatography resin or a membrane.

### Claim 39 (depends on 36)

The method of claim 36, wherein the peptide consists essentially of an amino acid sequence selected from the group consisting of SEQ ID NOs: 34, 39, 40, 50, 54 and 55.

### Claim 40 (depends on 27)

A method of separating, isolating, purifying, characterizing, identifying, or quantifying API in a sample, which method comprises (a) contacting a sample comprising API with the peptide of claim 27 to form an API-peptide complex, and (b) separating, isolating, purifying, characterizing, identifying, or quantifying the API-peptide complex.

### Claim 41 (depends on 40)

The method of claim 40, wherein the peptide is attached to a support.

### Claim 42 (depends on 41)

The method of claim 41, wherein the support is a chromatography resin or a membrane.

### Claim 43 (depends on 31)

A method of separating, isolating, purifying, characterizing, identifying, or quantifying API in a sample, which method comprises (a) contacting a sample comprising API with the peptide of claim 31 to form an API-peptide complex, and (b) separating, isolating, purifying, characterizing, identifying, or quantifying the API-peptide complex.

### Claim 44 (depends on 43)

The method of claim 43, wherein the peptide is attached to a support.

### Claim 45 (depends on 44)

The method of claim 44, wherein the support is a chromatography resin or a membrane.

### Claim 46 (depends on 34)

A method of separating, isolating, purifying, characterizing, identifying, or quantifying a protein complex comprising Apo-A1 lipoprotein and paraoxonase in a sample, which method comprises (a) contacting a sample comprising a protein complex comprising Apo-A1 lipoprotein and paraoxonase with the peptide of claim 34 to form a complex comprising Apo-A1 lipoprotein, paraoxonase, and the peptide of claim 34, and (b) separating, isolating, purifying, characterizing, identifying, or quantifying the complex.

### Claim 47 (depends on 46)

The method of claim 46, wherein the peptide is attached to a support.

### Claim 48 (depends on 47)

The method of claim 47, wherein the support is a chromatography resin or a membrane.

### Claim 49

An isolated or purified peptide comprising no more than 6 amino acids and comprising an amino acid sequence Xaa4-Xaa5-Xaa5, wherein
Xaa4 is a hydrophobic amino acid or an aromatic amino acid, and
Xaa5 is an acidic amino acid, and
wherein the peptide does not comprise His, Arg, or Lys, and binds to von Willebrand Factor (vWF).

### Claim 50 (depends on 49)

The isolated or purified peptide of claim 49, wherein Xaa5 is Asp or Glu.

### Claim 51 (depends on 49)

The isolated or purified peptide of claim 49, wherein the peptide consists essentially of an amino acid sequence selected from the group consisting of SEQ ID NOs: 64-66, 68-73, and 111.

### Claim 52 (depends on 49)

A composition comprising the peptide of claim 49 and a carrier.

### Claim 53

An isolated or purified peptide comprising no more than 10 amino acids and comprising an amino acid sequence Tyr-Leu-Xaa11-Xaa4-Xaa12-Thr, wherein
Xaa4 is a hydrophobic amino acid or an aromatic amino acid,
Xaa11 is an aromatic amino acid or His, and
Xaa12 is a hydrophobic amino acid or a polar amino acid, and
wherein the peptide binds to vWF.

### Claim 54 (depends on 53)

The isolated or purified peptide of claim 53, wherein the Xaa11 is His or Tyr, Xaa4 is Tyr or Ala, and Xaa12 is Gln or Leu.

### Claim 55

An isolated or purified peptide comprising no more than 10 amino acids and comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 67, 76, and 77, wherein the peptide binds to vWF.

### Claim 56 (depends on 49)

A method of separating, isolating, purifying, characterizing, identifying, or quantifying vWF in a sample, which method comprises (a) contacting a sample comprising vWF with the peptide of claim 49 to form a vWF-peptide complex, and (b) separating, isolating, purifying, characterizing, identifying, or quantifying the vWF-peptide complex.

### Claim 57 (depends on 56)

The method of claim 56, wherein the peptide is attached to a support.

### Claim 58 (depends on 57)

The method of claim 57, wherein the support is a chromatography resin or a membrane.

### Claim 59 (depends on 57)

The method of claim 57, wherein Factor VIII is bound to vWF, and the Factor VIII is co-purified with the vWF.

### Claim 60 (depends on 53)

A method of separating, isolating, purifying, characterizing, identifying, or quantifying vWF in a sample, which method comprises (a) contacting a sample comprising vWF with the peptide of claim 53 to form a vWF-peptide complex, and (b) separating, isolating, purifying, characterizing, identifying, or quantifying the vWF-peptide complex.

### Claim 61 (depends on 60)

The method of claim 60, wherein the peptide is attached to a support.

### Claim 62 (depends on 61)

The method of claim 61, wherein the support is a chromatography resin or a membrane.

### Claim 63 (depends on 61)

The method of claim 61, wherein Factor VIII is bound to vWF, and the Factor VIII is co-purified with the vWF.

### Claim 64 (depends on 55)

A method of separating, isolating, purifying, characterizing, identifying, or quantifying vWF in a sample, which method comprises (a) contacting a sample comprising vWF with the peptide of claim 55 to form a vWF-peptide complex, and (b) separating, isolating, purifying, characterizing, identifying, or quantifying the vWF-peptide complex.

### Claim 65 (depends on 64)

The method of claim 64, wherein the peptide is attached to a support.

### Claim 66 (depends on 65)

The method of claim 65, wherein the support is a chromatography resin or a membrane.

### Claim 67 (depends on 64)

The method of claim 64, wherein Factor VIII is bound to vWF, and the Factor VIII is co-purified with the vWF.
